Dublin, Oct. 25, 2022 (GLOBE NEWSWIRE) -- The "Intravenous (IV) Solutions - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Global Intravenous (IV) Solutions Market to Reach $16 Billion by 2027
Amid the COVID-19 crisis, the global market for Intravenous (IV) Solutions estimated at US$10.1 Billion in the year 2020, is projected to reach a revised size of US$16 Billion by 2027, growing at a CAGR of 6.8% over the period 2020-2027. Total Parenteral Nutrition, one of the segments analyzed in the report, is projected to record 7.1% CAGR and reach US$11 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Peripheral Parenteral Nutrition segment is readjusted to a revised 6% CAGR for the next 7-year period.
The U.S. Market is Estimated at $3.9 Billion, While China is Forecast to Grow at 8.4% CAGR
The Intravenous (IV) Solutions market in the U.S. is estimated at US$3.9 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 8.4% over the period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.2% and 6.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR.
Select Competitors (Total 67 Featured)
- Amanta Healthcare
- Anhui Medipharm Co., LTD.
- Axa Parenterals Ltd.
- B. Braun Melsungen Ag
- Baxter International Inc.
- Fresenius Kabi AG
- Grifols, S.A.
- ICU Medical, Inc.
- JW Life Science
- Otsuka Pharmaceutical Co. Ltd.
- Pfizer Inc.
- Salius Pharma Private Limited.
- Vifor Pharma Management Ltd.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Growing Prevalence of Malnutrition in Hospitalized Patients to Fuel Need for IV Solutions
- Rising Prevalence of Chronic Diseases and Resultant Need for Additional Nutrition Enhances Need to Administer IV Solutions
- Rising Cancer Incidence and Need for Nutritional Support
- Alarming Rise in Diabetes Incidence Worldwide
- Unrelenting Threat of HIV/AIDS Infection
- Nutritional Management of Patients with Neurological Diseases
- Concerns over Fluid Depletion from Body Due to GI & Diarrheal Diseases Necessitate IV Fluid Administration
- Growing Numbers of Pre-term Births Drives Demand for IV Solutions
- Demand Rises for Home Intravenous Nutritional Therapies
- Premixed IV Nutrition: A Step towards Safer Medication Practices
- Premixed Formulations Present Efficient Delivery System
- Iron Replacement Therapies: Potential for Growth
- Growing Demand for Low-Cost Intravenous Nutrition Solutions
- COVID-19 Outbreak: Combating Medication Errors in IV Infusion
- Aging Global Demography and Resultant Rise in Need for Nutrition Management Augurs Well for the Market
- Increasing Healthcare Expenditure Creates Conducive Environment
- Challenges Confronting IV Solutions Market
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/i3m9qj
Attachment
